Spray-on transdermal drug delivery systems

被引:17
|
作者
Ibrahim, Sarah A. [1 ]
机构
[1] Fairleigh Dickinson Univ, Sch Pharm, Div Pharmaceut Sci, Florham Pk, NJ 07932 USA
关键词
drug delivery; evaporative system; penetration enhancers; transdermal; transdermal spray system; HORMONE REPLACEMENT THERAPY; HUMAN EPIDERMAL MEMBRANE; FINITE DOSE ABSORPTION; HUMAN SKIN PENETRATION; ESTRADERM TTS(R) 50; PERCUTANEOUS-ABSORPTION; SUPERSATURATED SOLUTIONS; STRATUM-CORNEUM; D-LIMONENE; PERMEATION;
D O I
10.1517/17425247.2015.961419
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Transdermal drug delivery possesses superior advantages over other routes of administration, particularly minimizing first-pass metabolism. Transdermal drug delivery is challenged by the barrier nature of skin. Numerous technologies have been developed to overcome the relatively low skin permeability, including spray-on transdermal systems. Areas covered: A transdermal spray-on system (TSS) usually consists of a solution containing the drug, a volatile solvent and in many cases a chemical penetration enhancer. TSS promotes drug delivery via the complex interplay between solvent evaporation and drug-solvent drag into skin. The volatile solvent carries the drug into the upper layers of the stratum corneum, and as the volatile solvent evaporates, an increase in the thermodynamic activity of the drug occurs resulting in an increased drug loading in skin. Expert opinion: TSS is easily applied, delivering flexible drug dosage and associated with lower incidence of skin irritation. TSS provides a fast-drying product where the volatile solvent enables uniform drug distribution with minimal vehicle deposition on skin. TSS ensures precise dose administration that is aesthetically appealing and eliminates concerns of residual drug associated with transdermal patches. Furthermore, it provides a better alternative to traditional transdermal products due to ease of product development and manufacturing.
引用
收藏
页码:195 / 205
页数:11
相关论文
共 50 条
  • [21] Biopolymers as Transdermal Drug Delivery Systems in Dermatology Therapy
    Basavaraj, K. H.
    Johnsy, George
    Navya, M. A.
    Rashmi, R.
    Siddaramaiah
    [J]. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2010, 27 (02): : 155 - 185
  • [22] Transdermal drug delivery systems in diabetes management: A review
    Ng, Li Ching
    Gupta, Manish
    [J]. ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 15 (01) : 13 - 25
  • [23] TOWARDS SKIN COMPLIANT TRANSDERMAL DRUG DELIVERY SYSTEMS
    BODDE, HE
    TIEMESSEN, HLGM
    JUNGINGER, HE
    [J]. PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (02) : 150 - 150
  • [24] Recent advances in transdermal drug delivery systems: a review
    Woo Yeup Jeong
    Mina Kwon
    Hye Eun Choi
    Ki Su Kim
    [J]. Biomaterials Research, 25
  • [25] Recent advances in polymeric transdermal drug delivery systems
    Sabbagh, Farzaneh
    Kim, Beom Soo
    [J]. JOURNAL OF CONTROLLED RELEASE, 2022, 341 : 132 - 146
  • [26] Chemical Penetration Enhancers for Transdermal Drug Delivery Systems
    Pathan, Inayat Bashir
    Setty, C. Mallikarjuna
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2009, 8 (02) : 173 - 179
  • [27] TRANSDERMAL DRUG DELIVERY SYSTEMS - REPORT OF THE PMA COMMITTEE
    不详
    [J]. PHARMACOPEIAL FORUM, 1986, 12 (05): : 1798 - 1807
  • [28] Progress in transdermal drug delivery systems for cancer therapy
    Jiang, Tianyue
    Xu, Guo
    Chen, Guojun
    Zheng, Yu
    He, Bingfang
    Gu, Zhen
    [J]. NANO RESEARCH, 2020, 13 (07) : 1810 - 1824
  • [29] Progress in transdermal drug delivery systems for cancer therapy
    Tianyue Jiang
    Guo Xu
    Guojun Chen
    Yu Zheng
    Bingfang He
    Zhen Gu
    [J]. Nano Research, 2020, 13 : 1810 - 1824